Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC - an update from the PACIFIC trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021 (SCI Expanded İndekslerine Giren Dergi) identifier

The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer.

Medical oncology (Northwood, London, England), cilt.38, ss.11, 2021 (SCI Expanded İndekslerine Giren Dergi) identifier

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.

The New England journal of medicine, cilt.383, ss.1328-1339, 2020 (SCI Expanded İndekslerine Giren Dergi) identifier

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.

The New England journal of medicine, 2020 (SCI Expanded İndekslerine Giren Dergi) identifier

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.

The New England journal of medicine, cilt.381, ss.13-24, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

The New England journal of medicine, cilt.379, ss.2342-2350, 2018 (SCI İndekslerine Giren Dergi) Creative Commons License identifier identifier identifier

Effect of Induction Chemotherapy in the PACIFIC Study

JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.10, 2018 (SCI İndekslerine Giren Dergi) Creative Commons License identifier

Outcomes of Patients < 70 or >= 70 Years of Age in PACIFIC

JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.10, 2018 (SCI İndekslerine Giren Dergi) Creative Commons License identifier

Durvalumab in Stage III Non-Small-Cell Lung Cancer REPLY

NEW ENGLAND JOURNAL OF MEDICINE, cilt.378, sa.9, ss.869-870, 2018 (SCI İndekslerine Giren Dergi) identifier

Durvalumab in Stage III Non-Small-Cell Lung Cancer.

The New England journal of medicine, cilt.378, ss.869-870, 2018 (SCI İndekslerine Giren Dergi) identifier identifier

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

NEW ENGLAND JOURNAL OF MEDICINE, cilt.377, sa.20, ss.1919-1929, 2017 (SCI İndekslerine Giren Dergi) Creative Commons License identifier identifier identifier

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

NEW ENGLAND JOURNAL OF MEDICINE, cilt.377, sa.4, ss.352-360, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?

Hepato-Gastroenterology, cilt.62, sa.137, ss.59-64, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Receptor expression discrepancy between primary and metastatic breast cancer lesions

Oncology Research and Treatment, cilt.37, sa.11, ss.622-626, 2014 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Dendritic cell sarcoma: A pooled analysis including 462 cases with presentation of our case series

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, cilt.88, sa.2, ss.253-271, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Patterns of complementary and alternative medicine use among turkish cancer patients

Journal of Palliative Medicine, cilt.16, sa.4, ss.383-390, 2013 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Primary osteosarcoma of the heart: Experience of an unusual case

Case Reports in Oncology, cilt.6, sa.1, ss.224-228, 2013 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

Prognostic factors for survival in the phase III TROPIC trial.

JOURNAL OF CLINICAL ONCOLOGY, cilt.30, sa.5, 2012 (SCI İndekslerine Giren Dergi) identifier

Surgery for isolated liver metastasis of ovarian cancer

Asian Journal of Surgery, cilt.33, sa.2, ss.83-88, 2010 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Metastasis from breast carcinoma to endometrial polyp

European Journal of Gynaecological Oncology, cilt.29, sa.6, ss.666-668, 2008 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Determining predominating histologic component in malignant mixed müllerian tumors: Is it worth it?

International Journal of Gynecological Cancer, cilt.18, sa.4, ss.809-812, 2008 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

A case-control study of non-alcoholic fatty liver disease in breast cancer

Medical Oncology, cilt.24, sa.4, ss.367-371, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Neuroblastoma in adults, presentation of 2 cases

VIRCHOWS ARCHIV, cilt.451, sa.2, ss.577, 2007 (SCI İndekslerine Giren Dergi) identifier

Thymoma with chronic diarrhea: Report of two cases and review of the literature

Medical Oncology, cilt.24, sa.1, ss.119-123, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Paraneoplastic pemphigus associated with fludarabine use

Medical Oncology, cilt.24, sa.1, ss.115-118, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, cilt.13, sa.1, ss.13-18, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

C-reactive protein as an acute phase protein in cancer patients

Medical Oncology, cilt.24, sa.3, ss.338-344, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Megestrol acetate induced hypoadrenalism with cushingoid phenotype in endometrial cancer [1]

Gynecologic Oncology, cilt.101, sa.1, ss.183, 2006 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Devastating effects of chemotherapy: Deafness and acute renal failure in a patient with epithelial ovarian cancer

International Journal of Gynecological Cancer, cilt.16, ss.394-396, 2006 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Small cell carcinoma of the bladder: A case report and review of the literature

International Urology and Nephrology, cilt.38, sa.1, ss.15-19, 2006 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Delayed onset bleomycin-induced pneumonitis

UROLOGY, cilt.66, sa.1, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Does the incidence of anal canal cancers differ in Moslem societies?

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, cilt.20, sa.1, ss.76, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Rituximab-induced tumor progression: Does it really happen?

Medical Oncology, cilt.21, sa.2, ss.205-206, 2004 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Do we really benefit from checking tumor markers in detecting recurrence in gastrointestinal cancer?

Journal of B.U.ON., cilt.9, sa.2, ss.179-182, 2004 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

Should mammographic screening be done in primary ovarian cancer? A case control study in Turkish women

Medical Oncology, cilt.21, sa.2, ss.139-143, 2004 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Multiple primary tumors in cancer patients in a Turkish population

ANNALS OF ONCOLOGY, cilt.15, ss.149, 2004 (SCI İndekslerine Giren Dergi) identifier

Intrathoracic extravasation of antineoplastic agents - Case report and systematic review

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.26, sa.2, ss.121-123, 2003 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Flutamide-induced acute renal failure in a patient with metastatic prostate cancer.

Medical oncology (Northwood, London, England), cilt.19, sa.2, ss.117-9, 2002 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Simultaneous presentation of hepatocellular carcinoma in identical twin brothers

MEDICAL ONCOLOGY, cilt.19, sa.2, ss.113-116, 2002 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Metastatic cardiac myxoma

ANNALS OF THORACIC SURGERY, cilt.72, sa.2, ss.623-625, 2001 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Serum erythropoietin level in anemic cancer patients

MEDICAL ONCOLOGY, cilt.17, sa.1, ss.29-34, 2000 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma

American Journal of Clinical Oncology: Cancer Clinical Trials, cilt.22, sa.6, ss.615-618, 1999 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

Paraneoplastic hyperpigmentation secondary to lung cancer resolving after chemotherapy

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.22, sa.5, ss.533-534, 1999 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Anorectal melanoma metastatic to the breast

JOURNAL OF CLINICAL GASTROENTEROLOGY, cilt.29, sa.2, ss.197-199, 1999 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Chemoimmunotherapy protocol for advanced gastric cancer

EUROPEAN JOURNAL OF CANCER, cilt.35, 1999 (SCI İndekslerine Giren Dergi) identifier

Serum erythropoietin level in anemic cancer patients

EUROPEAN JOURNAL OF CANCER, cilt.35, 1999 (SCI İndekslerine Giren Dergi) identifier

Role of mammographic screening in ovarian cancer

EUROPEAN JOURNAL OF CANCER, cilt.35, 1999 (SCI İndekslerine Giren Dergi) identifier

Bilateral inflammatory breast metastases of epithelial ovarian cancer

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.22, sa.4, ss.408-410, 1999 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Serum cardiolipin antibodies in cancer patients with thromboembolic events

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.5, sa.3, ss.181-184, 1999 (SCI İndekslerine Giren Dergi) Creative Commons License identifier identifier identifier

Microangiopathic hemolytic anemia as an early predictor of recurrence in gastric cancer

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.22, sa.2, ss.214, 1999 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Anaphylaxis from intraperitoneal infusion of cisplatin - A case report

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.22, sa.2, ss.172-173, 1999 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma

Pathology and Oncology Research, cilt.5, sa.2, ss.123-128, 1999 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

Self expanding metal stents for palliation of dysphagia due to esophageal malignancies

Turkish Journal of Gastroenterology, cilt.10, sa.1, ss.18-23, 1999 (SCI Expanded İndekslerine Giren Dergi) identifier

Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma

INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, cilt.14, sa.3, ss.163-168, 1998 (SCI İndekslerine Giren Dergi) identifier identifier

Generalized telangiectasia as the major manifestation of angiotropic (intravascular) lymphoma

BRITISH JOURNAL OF DERMATOLOGY, cilt.137, sa.3, ss.422-425, 1997 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Magnetic resonance imaging of bone marrow versus biopsy in malignant lymphoma

EUROPEAN JOURNAL OF CANCER, cilt.33, ss.1220, 1997 (SCI İndekslerine Giren Dergi) identifier

NORADRENERGIC AND SEROTONINERGIC DEPRESSION

JOURNAL OF AFFECTIVE DISORDERS, cilt.27, sa.2, ss.123-129, 1993 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Spontaneous improvement of tardive dystonia during mania

British Journal of Psychiatry, cilt.158, ss.847-850, 1991 (SSCI İndekslerine Giren Dergi) identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

The treatment results of postoperative chemoradiotherapy in gastric carcinoma: Cerrahpasa experience

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, cilt.25, sa.1, ss.1-10, 2010 (ESCI İndekslerine Giren Dergi) identifier identifier

Skeletal muscle: An unusual site of distant metastasis in gastric carcinoma

Radiation Medicine - Medical Imaging and Radiation Oncology, cilt.24, sa.2, ss.150-153, 2006 (Diğer Kurumların Hakemli Dergileri) identifier identifier

Pentoxifylline in the Treatment of Radiation-related Pelvic Insufficiency Fractures of Bone

Radiation Medicine - Medical Imaging and Radiation Oncology, cilt.21, sa.5, ss.223-227, 2003 (Diğer Kurumların Hakemli Dergileri) identifier identifier

Kadınlarda primeri bilinmeyen aksiller karsinom metastazına yaklaşım: iki olgu bildirimi

Meme Hastalıkları Dergisi, cilt.5, ss.172-175, 1998 (Diğer Kurumların Hakemli Dergileri)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38 identifier

Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38 identifier

Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience

Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), Geneva, İsviçre, 11 - 14 Aralık 2019, cilt.30 identifier

First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC: Safety, pharmacokinetics (PK) and immunogenicity in CASPIAN

Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), Geneva, İsviçre, 11 - 14 Aralık 2019, cilt.30, ss.66 identifier

Three-year overall survival update from the PACIFIC trial

European-Society-for-Medical-Oncology (ESMO) Asia Congress, Singapore, Singapur, 22 - 24 Kasım 2019, cilt.30 identifier

PD-L1 expression, patterns of progression and patient-reported outcomes (PROs) with durvalumab plus platinum-etoposide in ES-SCLC: Results from CASPIAN

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, ss.928-929 identifier

Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, ss.592-593 identifier

A challenging task - Identifying carcinoma of unknown primary (CUP) patients according to ESMO guidelines: The CUPISCO trial experience

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30 identifier

Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged >= 65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37 identifier

Three-year overall survival update from the PACIFIC trial.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37 identifier

First subsequent treatment after discontinuation of durvalumab in unresectable, stage III NSCLC patients from PACIFIC.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37 identifier

PACIFIC: Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC

60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 21 - 24 Ekim 2018, cilt.102, ss.1607-1608 identifier

PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer

59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO), California, Amerika Birleşik Devletleri, 24 - 27 Eylül 2017, cilt.99, ss.1314-1315 identifier

LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35 identifier

Everolimus (EVE) plus endocrine therapy in patients with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (BC): First-and second-line data from the BOLERO-4 study.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35 identifier

Stomatitis in patients treated with first-line everolimus (EVE) plus letrozole (LET): Results from BOLERO-4 trial

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 6 - 10 Aralık 2016, cilt.77 identifier

Everolimus plus trastuzumab and vinorelbine for trastuzumabresistant, taxane-pretreated, HER2+advanced breast cancer: Overall survival results from BOLERO-3

38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 8 - 12 Aralık 2015, cilt.76 identifier

Response to cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) poorly responding to docetaxel

European Cancer Congress / 18th Meeting of the European-Cancer-Organization (ECCO) / 40th Meeting of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 25 - 29 Eylül 2015, cilt.51 identifier

Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 identifier

Prognostic factors of survival in patients with metastatic castration resistant prostate cancer (mCRPC) treated with cabazitaxel: Sequencing might matter

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 identifier

Thromboembolic complications in cancer patients.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 identifier

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 identifier

Preoperative Chemoradiotherapy Improves Local Recurrence Free Survival in Locally Advanced Rectal Cancer

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47 identifier

Tumour Characteristics Determining Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47 identifier

KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47 identifier

Cabazitaxel Plus Prednisone for Patients With Metastatic Castration-resistant Prostate Cancer Previously Treated With a Docetaxel-containing Regimen - Interim Analysis Results From an Ongoing Compassionate-use Programme

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47 identifier

INCREASING ROLE OF METASTASECTOMY IN METASTATIC BREAST CANCER PATIENTS: WHO BENEFITS MORE

35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, İtalya, 8 - 12 Ekim 2010, cilt.21, ss.111 identifier

THE EFFECTS OF PATIENT AND TUMOR CHARECTERISTICS AND TREATMENT MODALITIES ON PROGNOSIS OF PATIENTS WITH UVEAL MELANOMA

35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, İtalya, 8 - 12 Ekim 2010, cilt.21, ss.406 identifier

Is there any future of prophylactic cranial irradiation in adenocarcinoma of the lung?

15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, cilt.7, ss.534 identifier

The effects of prognostic factors on the first recurrence patterns of breast cancer

15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, cilt.7, ss.312 identifier

AWARENESS OF CANCER DIAGNOSIS IN TURKISH CANCER PATIENTS AND ATTITUDES OF PHYSICIANS AND NURSES TOWARDS DISCLOSURE OF THE DIAGNOSIS

33rd European-Society-for-Medical-Oncology Congress, Stockholm, İsveç, 12 - 16 Eylül 2008, cilt.19, ss.263 identifier

CHARACTERISTICS OF THROMBOEMBOLIC COMPLICATIONS IN CANCER PATIENTS

33rd European-Society-for-Medical-Oncology Congress, Stockholm, İsveç, 12 - 16 Eylül 2008, cilt.19, ss.256-257 identifier

Trastuzumab beyond progression in metastatic breast cancer

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.77 identifier

Imatinib mesylate response in Gastrointestinal Stromal Tumors: Experience of cerrahpasa medical faculty

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.164 identifier

The evaluation of toxicity and survival results of a phase II trial investigating the role of postoperative chemoradioimmunotherapy for gastric adenocarcinoma

23rd Annual Meeting of the European-Society-for-Therapeutic-Radiology-and-Oncology (ESTRO 23), Amsterdam, Hollanda, 24 - 28 Ekim 2004, cilt.73 identifier

Gastric cancer in Turkey: A single center experience of 683 cases

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22 identifier

Is the incidence of anal canal cancers different in Moslem societies?

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22 identifier

The acute phase proteins in cancer patients

56th Annual Meeting of the American-Association-for-Clinical-Chemistry, Los-Angeles, Şili, 25 - 29 Temmuz 2004, cilt.50 identifier

Significance of serum beta-2 microglobulin in epithelial ovarian cancer

35th Annual Meeting , American Society of Clinical Oncology., Atlanta, Amerika Birleşik Devletleri, 15 - 18 Mayıs 1999, cilt.1, ss.382

Chemoimmunotherapy protocol in patients with advanced gastric cancer

2nd Congress of the Balkan-Union-of-Oncology, İzmir, Türkiye, 10 - 14 Eylül 1998, ss.407-411 identifier

THE ROLE OF LOCAL RADIATION THERAPY IN NEOADJUVANT PROTOCOL OF OSTEOSARCOMA

2ND OSTEOSARCOMA RESEARCH CONFERENCE ABSTRACT BOOK, İtalya, 1 - 04 Kasım 1996, ss.21